Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 27,144 | 28,294 | 32,558 | 27,068 | 26,164 | -- |
| General And Administrative Expense | 27,144 | 28,294 | 32,558 | 27,068 | 26,164 | -- |
| Other Operating Expenses | 2,363 | 19,201 | 19,225 | 7,513 | 3,385 | -- |
| Operating Expense | 29,507 | 47,495 | 51,783 | 34,581 | 29,549 | -- |
| Operating Income | -29,507 | -47,495 | -51,783 | -34,581 | -29,549 | -- |
| EBIT | -29,507 | -47,495 | -51,783 | -34,581 | -29,549 | -- |
| Interest Income | 3,959 | 4,981 | 7,122 | 9,948 | 11,816 | -- |
| Interest Income Non Operating | 3,959 | 4,981 | 7,122 | 9,948 | 11,816 | -- |
| Net Interest Income | 3,959 | 4,981 | 7,122 | 9,948 | 11,816 | -- |
| Other Income Expense | 308,068 | 336,697 | 375,701 | -17,087 | -11,101 | -- |
| Special Income Charges | -13,971 | -- | -- | -160.00 | -13,588 | 0.00 |
| Write Off | -- | -- | -- | 0.00 | 0.00 | -- |
| Gain On Sale Of Security | 322,039 | 336,697 | 375,701 | -16,927 | 2,487 | -- |
| Pretax Income | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Tax Effect Of Unusual Items | 46,210 | 50,505 | 56,355 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Net Income From Continuing Operation Net Minority Interest | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Net Income Including Noncontrolling Interests | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Net Income Common Stockholders | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Net Income | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| EBITDA | -29,507 | -47,495 | -51,783 | -34,581 | -29,549 | -- |
| Normalized EBITDA | -337,575 | -384,192 | -427,484 | -17,494 | -18,448 | -- |
| Basic EPS | 0.02 | 0.02 | 0.02 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.02 | 0.02 | 0.02 | -- | 0.00 | 0.00 |
| Basic Average Shares | 18.5M | 18.5M | 18.5M | -- | 18.5M | 18.5M |
| Diluted Average Shares | 18.5M | 18.5M | 18.5M | -- | 18.5M | 18.5M |
| Total Unusual Items | 308,068 | 336,697 | 375,701 | -17,087 | -11,101 | -- |
| Total Unusual Items Excluding Goodwill | 308,068 | 336,697 | 375,701 | -17,087 | -11,101 | -- |
| Tax Rate For Calcs | 0.15 | 0.15 | 0.15 | 0.00 | 0.00 | -- |
| Normalized Income | 20,662 | 7,991 | 11,694 | -24,633 | -17,733 | -- |
| Diluted NI Availto Com Stockholders | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Impairment Of Capital Assets | 13,971 | -- | -- | 160.00 | 13,588 | -- |
| Insurance And Claims | 1,875 | 1,875 | 1,875 | 1,875 | 1,875 | -- |
| Net Income Continuous Operations | 282,520 | 294,183 | 331,040 | -41,720 | -28,834 | -- |
| Net Non Operating Interest Income Expense | 3,959 | 4,981 | 7,122 | 9,948 | 11,816 | -- |
| Other Gand A | 25,269 | 26,419 | 30,683 | 25,193 | 24,289 | -- |
| Salaries And Wages | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Expenses | 29,507 | 47,495 | 51,783 | 34,581 | 29,549 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 658,931 | 804,479 | 951,621 | 809,931 | 757,165 | -- |
| Cash Cash Equivalents And Short Term Investments | 2.4M | 2.2M | 2.1M | 1.8M | 1.8M | -- |
| Cash Financial | 658,931 | 804,479 | 951,621 | 809,931 | 757,165 | -- |
| Other Short Term Investments | 1.8M | 1.4M | 1.1M | 943,053 | 1.1M | -- |
| Accounts Receivable | 11,643 | 8,438 | 37,300 | 27,682 | 16,776 | -- |
| Receivables | 11,643 | 8,438 | 37,300 | 27,682 | 16,776 | -- |
| Prepaid Assets | 1,875 | 3,750 | 5,625 | -- | 1,875 | 3,750 |
| Other Current Assets | -- | -- | -- | -- | -1.00 | -- |
| Current Assets | 2.4M | 2.3M | 2.1M | 1.8M | 1.8M | -- |
| Net PPE | 2.5M | 2.3M | 2.2M | 2.2M | 2.2M | -- |
| Total Non Current Assets | 2.5M | 2.3M | 2.2M | 2.2M | 2.2M | -- |
| Total Assets | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Accounts Payable | 21,254 | 14,328 | 29,453 | 38,916 | 21,029 | -- |
| Payables | 31,532 | 22,545 | 40,275 | 41,882 | 23,831 | -- |
| Payables And Accrued Expenses | 31,532 | 22,545 | 40,275 | 41,882 | 23,831 | -- |
| Current Liabilities | 31,532 | 22,545 | 40,275 | 41,882 | 23,831 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 31,532 | 22,545 | 40,275 | 41,882 | 23,831 | -- |
| Common Stock | 11.9M | 11.9M | 11.9M | 11.9M | 11.9M | -- |
| Capital Stock | 11.9M | 11.9M | 11.9M | 11.9M | 11.9M | -- |
| Retained Earnings | -7.2M | -7.5M | -7.8M | -8.1M | -8.1M | -- |
| Common Stock Equity | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Stockholders Equity | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Total Equity Gross Minority Interest | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Total Capitalization | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Net Tangible Assets | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Tangible Book Value | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Working Capital | 2.4M | 2.2M | 2.1M | 1.7M | 1.8M | -- |
| Invested Capital | 4.9M | 4.6M | 4.3M | 4.0M | 4.0M | -- |
| Share Issued | 18.5M | 18.5M | 18.5M | 18.5M | 18.5M | -- |
| Ordinary Shares Number | 18.5M | 18.5M | 18.5M | 18.5M | 18.5M | -- |
| Dueto Related Parties Current | 10,278 | 8,217 | 10,822 | 2,966 | 2,802 | -- |
| Other Equity Interest | 176,766 | 176,766 | 176,766 | 176,766 | 176,766 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16,340 | -27,119 | -61,644 | -12,650 | -25,596 | -- |
| Cash Flow From Continuing Operating Activities | -16,340 | -27,119 | -61,644 | -12,650 | -25,596 | -- |
| Stock Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Change In Working Capital | 7,657 | 13,007 | -16,850 | 9,021 | -6,855 | -- |
| Changes In Account Receivables | -3,205 | -- | -- | -10,906 | -12,578 | -2,569 |
| Change In Receivables | -3,205 | 28,862 | -9,618 | -10,906 | -12,578 | -- |
| Change In Payables And Accrued Expense | 8,987 | -17,730 | -1,607 | 18,052 | 3,848 | -- |
| Change In Payable | 8,987 | -17,730 | -1,607 | 18,052 | 3,848 | -- |
| Other Non Cash Items | -- | -- | -- | -- | -- | 0.00 |
| Capital Expenditure | -129,208 | -120,022 | -5,705 | -22,149 | -114,953 | -- |
| Sale Of Investment | 0.00 | 0.00 | 209,038 | 87,565 | 0.00 | -- |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 209,038 | 87,565 | 0.00 | -- |
| Investing Cash Flow | -129,208 | -120,022 | 203,333 | 65,416 | -114,953 | -- |
| Cash Flow From Continuing Investing Activities | -129,208 | -120,022 | 203,333 | 65,416 | -114,953 | -- |
| Issuance Of Capital Stock | -- | -- | -- | 0.00 | 0.00 | -- |
| Net Common Stock Issuance | -- | -- | -- | 0.00 | 0.00 | -- |
| Financing Cash Flow | -- | -- | -- | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | -- | -- | -- | 0.00 | 0.00 | -- |
| Changes In Cash | -145,548 | -147,142 | 141,690 | 52,766 | -140,549 | -- |
| Beginning Cash Position | 804,479 | 951,621 | 809,931 | 757,165 | 897,714 | -- |
| End Cash Position | 658,931 | 804,479 | 951,621 | 809,931 | 757,165 | -- |
| Free Cash Flow | -145,548 | -147,141 | -67,349 | -34,799 | -140,549 | -- |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Interest Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Asset Impairment Charge | -- | -- | -- | 160.00 | 13,588 | -- |
| Capital Expenditure Reported | -129,208 | -120,022 | -5,705 | -22,149 | -114,953 | -- |
| Change In Account Payable | 6,926 | -15,125 | -9,463 | 17,887 | 3,878 | -- |
| Change In Prepaid Assets | 1,875 | 1,875 | -5,625 | -- | 1,875 | 1,875 |
| Common Stock Issuance | -- | -- | -- | 0.00 | 0.00 | -- |
| Gain Loss On Investment Securities | 0.00 | 0.00 | -55,738 | -18,265 | 0.00 | -- |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 | -- | -- |
| Net Income From Continuing Operations | 282,519 | 294,184 | 331,039 | -41,720 | -28,833 | -- |
| Net Other Investing Changes | -- | -- | -- | -- | -114,953 | -6,793 |
| Operating Gains Losses | 0.00 | 0.00 | -55,738 | -18,265 | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | -320,487 | -334,310 | -320,095 | 38,154 | -3,496 | -- |